Laffoon, Scott B.
Doecke, James D.
Roberts, Anne M.
Vance, Jennifer A.
Reeves, Benjamin D.
Pertile, Kelly K.
Rumble, Rebecca L.
Fowler, Chris J.
Trounson, Brett
Ames, David
Martins, Ralph
Bush, Ashley I.
Masters, Colin L.
Grieco, Paul A.
Dratz, Edward A.
Roberts, Blaine R. https://orcid.org/0000-0001-5466-0053
Funding for this research was provided by:
National Institutes of Health (5R42RR021790, 1P20RR024237)
National Health and Medical Research Council (1164692, 1138673)
Alzheimer's Drug Discovery Foundation
Article History
Received: 13 September 2021
Accepted: 23 December 2021
First Online: 26 January 2022
Declarations
:
: Ethical approval for this study was provided by The University of Melbourne Human Research Ethics Committee. Prior written informed consent was obtained from all participants.
: All authors consent that the details and images will be freely available on the internet. None of the authors are government employees. All authors consent to the manuscript, text, and pictures being published by Proteome Science and used for commercial purposes. All authors have read and approved of the manuscript.
: EAD and PAG are founders and shareholders in Zdye LLC, which licenses patents issued to Montana State University and reagents used in the present study. BRR, SBL and EAD are inventors on PCT application AU2014/000849. BRR receives research support from Agilent Technologies and from eMSion Inc. (OR, USA). All other authors declare that no competing interests exist.